Laparoendoscopic Single-Site Surgery for Urachal Remnants: A Single-Center Experience

Area of Science:

• Minimally Invasive Surgery
• Pediatric Surgery
• Urology

Background:

• Urachal remnants are rare congenital anomalies, typically diagnosed in younger patients.
• Surgical excision is the standard treatment for urachal remnants.
• Laparoscopic surgery is often preferred due to small specimen size and favorable outcomes.

Purpose of the Study:

• To evaluate the safety and efficacy of Laparoendoscopic Single-Site Surgery (LESS) for treating urachal remnants.
• To assess the cosmetic outcomes and postoperative pain associated with LESS for urachal remnants.

Main Methods:

• Retrospective review of 30 patients who underwent LESS for urachal remnants between January 2011 and December 2017.
• Analysis of patient demographics, surgical parameters, postoperative pain scores, and cosmetic assessments.
• Comparison of outcomes with conventional surgical techniques.

Main Results:

• LESS was successfully completed in all 30 patients without conversion to open surgery.
• Mean operative time was 151 minutes, with minimal blood loss (5.0 mL).
• Patients experienced early oral intake, ambulation on postoperative day 1, and a mean hospital stay of 5.5 days.

Conclusions:

• Laparoendoscopic Single-Site Surgery (LESS) is a viable and safe surgical option for urachal remnants.
• LESS may offer advantages in terms of reduced postoperative pain and excellent cosmetic results.
• Further research is needed to establish LESS as a standard treatment for urachal remnants.